The proliferation of online for-profit medical journals - 17/08/16
Doi : 10.1016/j.jaad.2016.02.1156
William W. Huang, MD, MPH a, Steven R. Feldman, MD, PhD a, b, c, ⁎ 
a Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC
b Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC
c Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC
∗Reprint requests: Steven R. Feldman, MD, PhD, Department of Dermatology, Wake Forest University School of Medicine, 4618 Country Club Rd, Winston-Salem, NC 27104.Department of DermatologyWake Forest School of Medicine4618 Country Club RdWinston-SalemNC27104
Key words : controversies, for profit, journals, open access, publications, research
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Disclosure: Dr Feldman is a consultant and speaker for Galderma, Stiefel/GlaxoSmithKline, Abbott Labs, Warner Chilcott, Janssen, Amgen, Photomedex, Genentech, BiogenIdec, and Bristol Myers Squibb; has received grants from Galderma, Astellas, Abbott Labs, Warner Chilcott, Janssen, Amgen, Photomedex, Genentech, BiogenIdec, Coria/Valeant, Pharmaderm, Ortho Pharmaceuticals, Aventis Pharmaceuticals, Roche Dermatology, 3M, Bristol Myers Squibb, Stiefel/GlaxoSmithKline, Novartis, Medicis, Leo, HanAll Pharmaceuticals, Celgene, Basilea, and Anacor; has received stock options from Photomedex; and is the founder of and holds stock in Causa Research. Dr Huang has no conflicts of interest to declare. |
© 2016
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 75 - N° 3
P. 656-657 - septembre 2016 Retour au numéro
Article précédent
- Radiation therapy (RT) for nonmelanoma skin cancer (NMSC), a cost comparison: Clarifying misconceptions
- Christopher M. Wolfe, Armand B. Cognetta
- Change of Address
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?